Oncotelic Therapeutics, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
25-NSE
3
4
4/A
424B2
424B3
424B4
424B5
424B7
425
5
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRE 14C
PRER14A
PRER14C
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-4
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001493152-26-004237 | Jan 29, 2026 | Jan 23, 2026 |
| 8-K | 8-K | 0001493152-26-003606 | Jan 26, 2026 | Jan 22, 2026 |
| 4 | 4 | 0001493152-26-003634 | Jan 26, 2026 | Jan 22, 2026 |
| 8-K | 8-K | 0001493152-26-000821 | Jan 7, 2026 | Jan 2, 2026 |
| 8-K | 8-K | 0001493152-26-000619 | Jan 6, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001493152-26-000613 | Jan 6, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001493152-25-029634 | Dec 30, 2025 | Dec 23, 2025 |
| 424B3 | 424B3 | 0001493152-25-029081 | Dec 23, 2025 | — |
| EFFECT | — | 9999999995-25-003907 | Dec 23, 2025 | — |
| 8-K | 8-K | 0001493152-25-028921 | Dec 23, 2025 | Dec 22, 2025 |
| S-1/A | S-1/A | 0001493152-25-028813 | Dec 22, 2025 | — |
| D | — | 0001493152-25-027270 | Dec 11, 2025 | — |
| 8-K | 8-K | 0001493152-25-026883 | Dec 9, 2025 | Dec 4, 2025 |
| S-1 | S-1 | 0001493152-25-024676 | Nov 21, 2025 | — |
| 4 | — | 0001493152-25-024236 | Nov 19, 2025 | Nov 17, 2025 |
| 10-Q | 10-Q | 0001493152-25-023834 | Nov 17, 2025 | Sep 30, 2025 |
| NT 10-Q | NT 10-Q | 0001493152-25-023634 | Nov 14, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001493152-25-018877 | Oct 22, 2025 | Oct 21, 2025 |
| 10-Q | 10-Q | 0001641172-25-023568 | Aug 13, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001641172-25-023189 | Aug 12, 2025 | Aug 6, 2025 |
| 8-K | 8-K | 0001641172-25-022361 | Aug 6, 2025 | Jul 31, 2025 |
| 4 | — | 0001641172-25-018620 | Jul 10, 2025 | Jul 8, 2025 |
| 10-Q | 10-Q | 0001641172-25-010984 | May 15, 2025 | Mar 31, 2025 |
| 424B3 | — | 0001641172-25-006597 | Apr 29, 2025 | — |
| EFFECT | — | 9999999995-25-001157 | Apr 21, 2025 | — |
| POS AM | — | 0001641172-25-004872 | Apr 15, 2025 | — |
| 10-K | — | 0001641172-25-004846 | Apr 15, 2025 | Dec 31, 2024 |
| NT 10-K | — | 0001641172-25-001610 | Mar 31, 2025 | Dec 31, 2024 |
| 8-K | — | 0001641172-25-000537 | Mar 25, 2025 | Mar 23, 2025 |
| 4 | — | 0001493152-25-004486 | Jan 31, 2025 | Jan 29, 2025 |
| 8-K | — | 0001493152-25-000028 | Jan 2, 2025 | Dec 31, 2024 |
| 4 | — | 0001493152-24-047762 | Nov 26, 2024 | Nov 22, 2024 |
| 10-Q | — | 0001493152-24-046867 | Nov 19, 2024 | Sep 30, 2024 |
| NT 10-Q | — | 0001493152-24-046049 | Nov 14, 2024 | Sep 30, 2024 |
| 4 | — | 0001493152-24-033939 | Aug 27, 2024 | Aug 23, 2024 |
| 10-Q | — | 0001493152-24-031995 | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | — | 0001493152-24-019332 | May 15, 2024 | Mar 31, 2024 |
| 8-K | — | 0001493152-24-016839 | Apr 29, 2024 | Apr 26, 2024 |
| 424B3 | — | 0001493152-24-016079 | Apr 26, 2024 | — |
| EFFECT | — | 9999999995-24-001057 | Apr 22, 2024 | — |
| POS AM | — | 0001493152-24-015239 | Apr 18, 2024 | — |
| POS AM | — | 0001493152-24-014484 | Apr 12, 2024 | — |
| 10-K | — | 0001493152-24-014475 | Apr 12, 2024 | Dec 31, 2023 |
| NT 10-K | — | 0001493152-24-012495 | Apr 1, 2024 | Dec 31, 2023 |
| 8-K | — | 0001493152-24-004783 | Feb 2, 2024 | Jan 29, 2024 |
| 10-Q | — | 0001493152-23-040804 | Nov 14, 2023 | Sep 30, 2023 |
| 8-K | — | 0001493152-23-038620 | Oct 30, 2023 | Oct 24, 2023 |
| 8-K | — | 0001493152-23-029903 | Aug 23, 2023 | Aug 21, 2023 |
| 10-Q | — | 0001493152-23-029461 | Aug 18, 2023 | Jun 30, 2023 |
| NT 10-Q | — | 0001493152-23-028688 | Aug 15, 2023 | Jun 30, 2023 |